Generation of Fcabs targeting human and murine LAG-3 as building blocks for novel bispecific antibody therapeuticsMETHODSIF4.32019-02-0123PREAI
Dual blockade of PD-L1 and LAG-3 with FS118, a unique bispecific antibody, induces CD8+T-cell activation and modulates the tumor microenvironment to promote antitumor immune responsesCANCER RESEARCHIF16.62018-07-0113PRE
A LAG-3/PD-L1 bispecific antibody inhibits tumor growth in two syngeneic colon carcinoma modelsCANCER RESEARCHIF16.62017-07-010PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向